Main features of the enrolled patients are summarised in table 1, compared to an equally sized random sample of patients suffering from SEA and treated with anti-IL-5/IL-5-receptor from the Southern Italy Network on Severe Asthma Therapy database. Here, IL5 is linked to asthma.